Ronald Nahass

6PUBLICATIONS
31CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 22, 2025
Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study.

Amy E Colson, Gordon E Crofoot, Peter J Ruane

|Nov 21, 2023
The Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis.

Savanna SanFilippo, Jacques Turgeon, Veronique Michaud

|Feb 25, 2023
Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin-Preclinical and Clinical Evidence.

Luigi Brunetti, Helene Chapy, Ronald G Nahass

|Aug 08, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.

Jason Grebely, Gregory J Dore, Frederick L Altice

|Nov 10, 2020
Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis.

Thomas S Hong, Jimmy Gonzalez, Ronald G Nahass

|Jun 29, 2018
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.

Benjamin Y Winer, Elham Shirvani-Dastgerdi, Yaron Bram

Pageof 1

Frequent Collaborators

3 joint publications

Luigi Brunetti

1 joint publications

Benjamin Y Winer

1 joint publications

Elham Shirvani-Dastgerdi

1 joint publications

Yaron Bram